H:S Rigshospitalet
Records under this name other than patents H:S Rigshospitalet holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to H:S Rigshospitalet
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,084,122 | Use of Glycosides of Mono- and Diacylglycerol as Anti-Inflammatory Agents Formerly held Term ended Term ended Dec 1, 2022 · High confidence | Term ended | Term ended Dec 1, 2022 | High confidence |
| US 7,622,101 | Developmental animal model of temporal lobe epilepsy Formerly held Lapsed on the fee record Ended Nov 24, 2021 · USPTO record | Lapsed on the fee record | Ended Nov 24, 2021 | USPTO record |
| US 7,034,201 | Developmental animal model of temporal lobe epilepsy Formerly held Lapsed on the fee record Ended Apr 25, 2018 · USPTO record | Lapsed on the fee record | Ended Apr 25, 2018 | USPTO record |
| US 8,586,298 | Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia Formerly held Lapsed on the fee record Ended Nov 19, 2017 · High confidence | Lapsed on the fee record | Ended Nov 19, 2017 | High confidence |
| US 7,521,589 | Developmental animal model of temporal lobe epilepsy Formerly held Lapsed on the fee record Ended Apr 21, 2017 · USPTO record | Lapsed on the fee record | Ended Apr 21, 2017 | USPTO record |